Pharmacyte BiotechPMCB
13F holders, Q1 2025 (March 31)24holders +3
4new positions
1sold out
1famous investor
$1.25avg. 13F price*
At the end of Q1 2025, 24 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings, up 3 from Q4 2024. 4 opened new positions and 1 sold out. The largest holders were Vanguard Group Inc. ($243K), Geode Capital Management, LLC ($174K) and Equitec Proprietary Markets, LLC ($103K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $4K |
| Exits | 1 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 16,687 shares bought and 49,251 shares sold, net −32,564 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Vanguard Group Inc. | 0.00% | Add +1.1% | 194,518 | $243K |
| Geode Capital Management, LLC | 0.00% | Reduce -15.7% | 138,935 | $174K |
| Equitec Proprietary Markets, LLC | 0.30% | No change | 82,727 | $103K |
| Renaissance Technologies | 0.00% | Add +0.4% | 49,500 | $62K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -0.8% | 25,500 | $32K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -24.4% | 20,299 | $25K |
| Northern Trust Corp. | 0.00% | No change | 19,208 | $24K |
| Susquehanna International Group, LLP | 0.00% | Reduce -46.6% | 18,406 | $23K |
| UBS Group AG | 0.00% | Add +535.9% | 11,916 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +40.6% | 3,438 | $4K |
| National Bank of Canada | 0.00% | New | 3,300 | $4K |
| Bank of America Corp. | 0.00% | Reduce -6.4% | 73 | $92 |
| Park Square Financial Group, LLC | 0.00% | No change | 37 | $46 |
| JPMorgan Chase & Co. | 0.00% | Reduce -11.1% | 16 | $20 |
| Sachetta, LLC | 0.00% | No change | 14 | $18 |
| BlackRock, Inc. | 0.00% | New | 14 | $18 |
| Osaic Holdings, Inc. | 0.00% | Reduce -98.1% | 10 | $12 |
| FMR LLC | 0.00% | New | 6 | $8 |
| Bfsg, LLC | 0.00% | No change | 5 | $7 |
| NewEdge Advisors, LLC | 0.00% | No change | 2 | $3 |
| Morgan Stanley | 0.00% | Reduce -50.0% | 1 | $2 |
| IFP Advisors, Inc | 0.00% | New | 1 | $1 |
| Cwm, LLC | 0.00% | No change | 1 | $0 |
| Covestor Ltd | 0.00% | No change | 275 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.